Sofinnova Bioequities Master Fund, LTD.
Sofinnova Bioequities Master Fund, LTD. is a hedge fund organized in Cayman Islands and advised by Sofinnova Investments, Inc. Its adviser reported $203,648,063 in gross assets for the fund on Form ADV, filed Sep 27, 2024. It reported 50 beneficial owners, about 11% of it owned by non-U.S. persons. The minimum investment it accepts is $3,000,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers.
- Gross assets
- $203,648,063As reported on Form ADV
- Beneficial owners
- 50
- Minimum investment
- $3,000,000
- Who can invest
- Qualified purchasersSection 3(c)(7)
- Fund type
- Hedge fund
- Domicile
- Cayman Islands
- Auditor
- KPMG, LLP
- Administrator
- Citco Fund Administration (Cayman Islands) Limited
- Prime broker
- Jefferies LLC; J.P. Morgan Securities Inc.; Goldman Sachs & Co. LLC
- Custodian
- Goldman Sachs International; Goldman Sachs & Co. LLC; BNY Mellon Trust Company (Ireland) Limited; Citco Bank Canada
- Adviser
- Sofinnova Investments, Inc. · Menlo Park, CA · CRD 160297
- Reported on
- Sep 27, 2024Adviser's Form ADV
From SEC filings, not verified. This information is republished from the adviser's Form ADV (Schedule D, Section 7.B.(1)) in the SEC's public Form ADV data, which currently runs through filings made by Dec 26, 2024. Figures are as of the adviser's filing and may have changed since. It is not an offer, solicitation or recommendation, AltMountain has not reviewed the fund, and gross assets are not performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Sofinnova Bioequities Master Fund, LTD.
What is the minimum investment for Sofinnova Bioequities Master Fund, LTD.?
According to its adviser's Form ADV filed Sep 27, 2024, the minimum investment Sofinnova Bioequities Master Fund, LTD. accepts is $3,000,000.
Who can invest in Sofinnova Bioequities Master Fund, LTD.?
Sofinnova Bioequities Master Fund, LTD. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7).
How large is Sofinnova Bioequities Master Fund, LTD.?
Its adviser reported $203,648,063 in gross assets on Form ADV filed Sep 27, 2024. Gross assets include borrowed money and are not the same as net assets or performance.
Who manages Sofinnova Bioequities Master Fund, LTD.?
Sofinnova Bioequities Master Fund, LTD. is advised by Sofinnova Investments, Inc., based in Menlo Park, CA.
Who are Sofinnova Bioequities Master Fund, LTD.'s service providers?
Its Form ADV lists KPMG, LLP as auditor and Citco Fund Administration (Cayman Islands) Limited as administrator.